Weston Nichols Net Worth & Insider Trades

Weston Nichols Tscan Therapeutics, Inc

As of June 2, 2023

What is Weston Nichols's Net Worth?

The current estimated net worth of Tscan Therapeutics, Inc's Weston Nichols is estimated to be about $13.97M . Weston Nichols owns about 5,224,600 units of Tscan Therapeutics, Inc common stock. Recently at Tscan Therapeutics, Inc, Weston Nichols has sold an estimated value of $63.95K worth.

What is Weston Nichols's Past Insider Trading?

Weston Nichols's largest sale order was 25,400 units , worth over $63.95K on June 2, 2023. In total, Weston Nichols has made about 1 transaction recently at Tscan Therapeutics, Inc. Weston Nichols usually trades in June, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lynx Capital Management LP, Weston Nichols

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Weston Nichols's' Mailing Address?

  • Mailing address is C/o Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg. #2 San Diego CA 92121 CA

What are Tscan Therapeutics, Inc's Past Insider Trades?

Tscan Therapeutics, Inc's most recent insider trade came on June 6, 2023 by Timothy Barberich who bought 37,880 units worth $99.56K . In the last 2 years, insiders at Tscan Therapeutics, Inc have sold an estimated value of $63.95K and bought an estimated value of $26.56M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Brian M Silver, Chief Financial Officer,  David P Southwell, Chief Executive Officer,  and Zoran Zdraveski, Chief Legal Officer .

TScan Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...